Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should patients with stable coronary artery disease be treated with ACE inhibitor therapy?

Nature Clinical Practice Cardiovascular Medicine volume 2, pages 124–125 (2005)Cite this article

boxed-textThe PEACE trial investigators (2004) Angiotensin-Converting-Enzyme Inhibition in Stable Coronary Artery Disease. N Engl J Med 351: 2058–2068

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342: 821–828

  2. The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327: 685–691

  3. The Heart Outcomes Prevention Evaluation Study Investigators (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in highrisk patients. N Engl J Med 342: 145–153

  4. Fox KM (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362: 782–788

    Article  CAS  Google Scholar 

  5. Pilote L et al. (2004) Mortality Rates in Elderly Patients Who Take Different Angiotensin-Converting Enzyme Inhibitors After Acute Myocardial Infarction: A Class Effect? Ann Intern Med 141: 102–112

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. William Osler Health Centre, Brampton, Ontario

    Milan Gupta

  2. McMaster University, Hamilton, Canada

    Milan Gupta

  3. Professor of Medicine and Cardiology at McMaster University,

    Eva M Lonn

  4. Scientist and Assistant Professor in the Division of Cardiac Surgery at the University of Toronto, Canada

    Subodh Verma

Authors
  1. Milan Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eva M Lonn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Subodh Verma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Subodh Verma.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gupta, M., Lonn, E. & Verma, S. Should patients with stable coronary artery disease be treated with ACE inhibitor therapy?. Nat Rev Cardiol 2, 124–125 (2005). https://doi.org/10.1038/ncpcardio0123

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0123

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing